Assessment of methods for prediction of human West Nile virus (WNV) disease from WNV-infected dead birds by Veksler, Anna et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
Emerging Themes in Epidemiology
Open Access Methodology
Assessment of methods for prediction of human West Nile virus 
(WNV) disease from WNV-infected dead birds
Anna Veksler1, Millicent Eidson*1,2 and Igor Zurbenko1
Address: 1School of Public Health, University at Albany, One University Place, Rensselaer, New York 12144, USA and 2Zoonoses Program, New 
York State Department of Health, 621 Corning Tower, Empire State Plaza, Albany, New York 12237, USA
Email: Anna Veksler - annaveksler@yahoo.com; Millicent Eidson* - mxe04@health.state.ny.us; Igor Zurbenko - igorg.zurbenko@gmail.com
* Corresponding author    
Abstract
Background:  West Nile virus (WNV) is currently the leading cause of arboviral-associated
encephalitis in the U.S., and can lead to long-term neurologic sequelae. Improvements in dead bird
specimen processing time, including the availability of rapid field laboratory tests, allows
reassessment of the effectiveness of using WNV-positive birds in forecasting human WNV disease.
Methods: Using New York State integrated WNV surveillance data from transmissions seasons
in 2001–2003, this study determined which factors associated with WNV-positive dead birds are
most closely associated with human disease. The study also addressed the 'delay' period between
the distribution of the dead bird variable and the distribution of the human cases. In the last step,
the study assessed the relative risk of contracting WNV disease for people who lived in counties
with a 'signal' value of the predictor variable versus people who lived in counties with no 'signal'
value of the predictor variable.
Results: The variable based on WNV-positive dead birds [(Positive/Tested)*(Population/Area)]
was identified as the optimum variable for predicting WNV human disease at a county level. The
delay period between distribution of the variable and human cases was determined to be
approximately two weeks. For all 3 years combined, the risk of becoming a WNV case for people
who lived in 'exposed' counties (those with levels of the positive dead bird variable above the signal
value) was about 2 times higher than the risk for people who lived in 'unexposed' counties, but risk
varied by year.
Conclusion: This analysis develops a new variable based on WNV-positive dead birds, [(Positive/
Tested)*(Population/Area)] to be assessed in future real-time studies for forecasting the number
of human cases in a county. A delay period of approximately two weeks between increases in this
variable and the human case onset was identified. Several threshold 'signal' values were assessed
and found effective at indicating human case risk, although specific thresholds are likely to vary by
region and surveillance system differences.
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Background
West Nile virus (WNV) was first recognized in the North-
east United States in 1999 [1]. Since 1999 the virus has
spread across the country, resulting in 28,943 human
cases and 1130 deaths through 2008 (reported as of Feb-
ruary 13, 2009) [2]. WNV is now found throughout the
western hemisphere [3]. Infection can lead to long-term
neurologic sequelae in people [4], and is currently the
leading cause of arboviral-type encephalitis in the U.S. [5].
The number of human cases reported to the Centers for
Disease Control and Prevention (CDC) currently varies
widely in the U.S., from a low of 1 case in North Carolina,
South Carolina and West Virginia in 2006 to a high of 996
cases in Idaho [6]. Some of this variation can be attributed
to different human population sizes and surveillance sys-
tems for infection, with some states more aggressive at
testing and reporting milder, non-neuroinvasive disease.
Although most WNV exposures do not result in clinical
disease and most disease is mild, with case fatality rates
ranging from 3% to 15% [7] disease prevention should be
a priority. Personal protective measures and mosquito
control measures all have a resource cost, and thus it is
important to try and determine when the risk of human
infection is high or low so that individuals and govern-
mental agencies can make appropriate decisions about
prevention.
Dead bird surveillance has served as one key method for
tracking WNV activity in the U.S. [8-10]. Previous studies
have documented that dead crow sightings can serve as a
valuable index for forecasting human cases before or with-
out laboratory confirmation of WNV infection, because
crows have had a case-fatality rate close to 100% and are
reasonably easy for the public to recognize and report
[11,12]. Multiple laboratory diagnostic methods may be
used for serologic and virologic diagnosis of WNV,
although collection, submission, processing, and testing
can be lengthy [13,14]. Thus, dead crow sightings, which
can be used for surveillance immediately upon reporting,
provide a more immediate indicator of WNV activity than
WNV-positive birds. However, more rapid processing
methods are in use in many areas, including VecTest and
RAMP, that can be used to provide a laboratory result
from swabs taken where the bird is found [13,15]. Devel-
opment of dead bird indicators using only WNV-positive
birds eliminates the possibility of misclassification inher-
ent in a dead crow sighting index, and it allows use of
other species, which is particularly important in areas
with few crows or other corvids (blue jays, ravens), or
where WNV has reduced the crow population. Previous
studies have indicated that WNV is sometimes first
detected in an area in a bird species other than a corvid
[16].
This study is an exploratory study focusing on determin-
ing which factors, using WNV-positive and tested dead
birds, are most closely associated with the number of
human WNV cases at a county level. The study also
addresses the issue of "delay" between the distribution of
a predictor variable based on laboratory-tested dead birds
and the distribution of human disease. Previous studies
have noted that the time between mosquito bites and
human disease onset (incubation period) is 2–14 days
[17]. This study expands upon prior analyses by consider-
ing daily distributions of the predictor variable and
human disease and applying statistical methods to assess
the "delay" period between these variables. Finally, this
study assesses the predictive value for the risk of human
disease of using a weekly county level predictor variable
based on WNV-positive and tested dead birds with several
signal levels.
Analysis
Data
To identify measures of WNV activity in birds that might
provide an indication of increased risk in humans, analy-
ses focused on NYS integrated WNV surveillance data col-
lected during the transmission season, defined as a 16-
week period using weeks as defined for reporting by the
CDC as the 26th week to the 41st week for the years 2001–
2003 (June 24–Oct. 13 in 2001, June 23–Oct. 12 in 2002,
and June 22–Oct. 11 in 2003). This time frame was opti-
mal for inclusion of all human disease in New York State.
The NYS integrated surveillance system includes real-time
surveillance components for humans, mammals, birds,
and mosquitoes. The surveillance system relies on the
public to report sightings of dead birds to local health
departments (LHDs). Some of the reported dead birds
were collected and tissue specimens were tested for WNV
infection at the NYSDOH Wadsworth Center's Arthropod-
borne Disease Laboratory, according to laboratory proto-
cols previously described [18].
For WNV surveillance in humans, healthcare providers
were asked to report patients with encephalitis and aseptic
meningitis to the LHDs. Thus, the NYSDOH surveillance
system emphasizes reporting of human cases with neu-
roinvasive disease, although cases without neuroinvasive
disease are not excluded. Patients were tested for WNV
infection at the NYSDOH Wadsworth Center's Diagnostic
Immunology Laboratory (serology), Arbovirus Labora-
tory (PRNT), and Viral Encephalitis Laboratory (PCR),
according to laboratory protocols previously described
[19].
According to the CDC case definitions, New York (exclud-
ing New York City) had six (one excluded from study)Emerging Themes in Epidemiology 2009, 6:4 http://www.ete-online.com/content/6/1/4
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confirmed or probable human WNV cases disease in
2001, 52 (three excluded) in 2002 and 40 (three
excluded) in 2003. Two counties had human WNV cases
in 2001, 12 counties had human WNV cases in 2002, and
ten counties reported WNV human cases in 2003. Data
from 57 NYS counties were included in this study. New
York City data were excluded from analysis because New
York City developed its own WNV surveillance system to
monitor dead bird reports, with different priorities for
reporting.
These analyses were conducted with county as the unit of
analysis for several reasons. The small number of human
cases made further subdivision challenging. In addition,
the actual location of infection for humans and birds is
unknown, so county can serve as a reasonable surrogate,
acknowledging the potential for misclassification and
reduced statistical power if infection actually occurred in
a different county. Finally, these analyses were conducted
to aid in prevention and control decision-making, which
occurs at the county level.
Variables measuring WNV activity in dead birds
To characterize the intensity of the WNV activity in birds
during the mosquito season for each county, eight varia-
bles were constructed empirically from bird surveillance
variables as potential candidates for a predictor variable
based on dead birds tested and confirmed with WNV at
the laboratory. One set of variables was constructed by
standardizing the surveillance variables WNV-positive
birds and tested birds by county land area, 2000 human
population estimates from the U.S. Census Bureau, or by
human population density. These variables were desig-
nated as A1 through A5 (Table 1). Another set of con-
structed variables accounted for the intensity of the bird
epizootic as measured by the proportion of tested birds
that were positive for WNV (A6), or proportion of tested
birds that were positive for WNV, standardized by human
population or population density (A7, A8).
To determine the significant variables among the eight
variables considered as potential predictor variables using
WNV-positive and/or tested dead birds, a correlation
matrix between each of the variables for every county with
at least one human case and the human cases in each
county across all three years was generated using SAS soft-
ware. The variables were considered as highly correlated
with human disease if p ≤ 0.05. Multiple regression was
then used to determine the best model predicting the
number of human disease cases using the adjusted R2 sta-
tistic (adjusted for the number of parameters in the
model) [20].
Delay period
Previous studies have noted that WNV-positive dead birds
are usually found before the onset of the human infection
[21,22]. Studies in the eastern U.S. found that the delay
period between the first WNV-positive bird and the first
human case varied from 15 days to 92 days [22]. Possible
explanations for the delay include the amplification cycle
between birds and mosquitoes and the transmission cycle
from mosquitoes to humans through mosquito bites. The
time between the exposure (mosquito bite) and onset of
human disease (incubation period) is known to be two to
14 days [17]. To determine the delay period for our study,
the distribution of the variable with the highest correla-
tion with human disease for every day of the transmission
period across all counties and for all three years pooled
together was considered.
To obtain the best estimate of the delay period between
the occurrence of WNV-positive birds and onset of human
disease, we calculated the mean value of the optimal pre-
dictor dead bird variable for every day of the transmission
period across all counties with human cases for all three
years. The study period each year was 16 weeks (113
days). For each of the 113 days for every county with
human cases we found the values of the predictor variable
identified in the previous modeling for the particular day,
then summarized them across all counties and divided the
sum by 24, the number of counties with human cases in
2001–2003. If no birds were tested on that day, then the
predictor variable was considered as zero.
To determine the delay period, two methods, non-para-
metric and parametric, were considered. The non-para-
Table 1: Variables constructed empirically from positive bird and tested bird surveillance variables
Surveillance variables standardized by population of county, area of 
county, or population density a
Proportion of positive birds and proportion of positive birds 
standardized by population or population density
A1 = [Positive/Area] A6 = [Positive/Tested]
A2 = [Tested/Area] A7 = [(Positive/Tested)*Population]
A3 = [Positive/Population] A8 = [(Positive/Tested)*(Population/Area)]
A4 = [Positive*(Population/Area)]
A5 = [Tested*(Population/Area)]
a Positive = WNV-positive dead birds; Tested = WNV-tested dead birds; Area = county land area in square miles; Population = county human 
population (U. S. Census Bureau, 2000 estimates)Emerging Themes in Epidemiology 2009, 6:4 http://www.ete-online.com/content/6/1/4
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metric two-sample Kolmogorov-Smirnov test was used to
test whether the two underlying probability distributions
of the predictor variable and human disease differed sig-
nificantly [23]. This test was performed using SAS soft-
ware with the proc npar1way, edf option. By shifting the
values of our variable against the daily distribution of
human cases, the best shift in days that maximized good-
ness of fit between two distributions was determined. The
second (parametric) method was applied to smoothed
daily distributions of our predictor variable and human
cases. The goal of this method was to maximize correla-
tion between two distributions over different shifts and
select the shift that provides the maximum. This test was
performed using SAS proc corr for every value of shift.
Estimation of WNV disease risk
The Cochran-Mantel-Haenszel (CMH) test was used to
calculate point and interval estimates for the relative risk
of becoming a human WNV case depending on the value
of the predictor variable in a person's county of residence.
For each week, a table was constructed comparing the
week's human cases per population in counties with a
"signal" value of the predictor variable (greater than a
threshold pre-determined for county use based on prelim-
inary estimates) and the human cases per population in
counties with no signal. Analyses were conducted with a
weekly distribution of the predictor variable, to avoid
small numbers or zeroes in daily distributions. The CMH
chi-square statistic was used to compare the incidence
(risk) of WNV disease in signal areas with the incidence in
the non-signal areas over all the weeks of study. The CMH
test was performed for several threshold values of the pre-
dictor variable using SAS Proc freq to obtain the estimate
of odds ratio and relative risk [SAS System for Windows
V8, SAS Institute, Cary, NC, USA].
The county was included in the CMH analysis if it tested
at least 10 birds during the transmission period. In 2001,
only 16 counties tested at least 10 birds. In 2002, 53 coun-
ties tested at least 10 birds. In 2003, 48 counties tested at
least 10 birds. All counties with human cases, except one,
were retained in the analysis because they all tested at least
10 birds during the transmission period. The exception
was Schuyler County with a human case in 2003 but only
five birds tested. This county was excluded from analysis
in 2003.
In the CMH analysis, data were included from each week
with onset of human cases – in 2001, from 8/19 to 9/22
(weeks 34 to 38), in 2002, from 7/28 to 10/5 (weeks 31 to
40), and in 2003, from 8/3 to 9/27 (weeks 32 to 39). For
each week, we constructed a table that compared the
number of persons with disease in counties with a "sig-
nal" (the predictor variable greater than or equal to the
threshold value) and the number of persons without dis-
ease (population minus disease cases) with the number of
persons with disease in counties without a "signal" and
the number of persons without disease. A template for the
weekly tables is presented in Table 2.
Results
Association of WNV-positive dead birds with human WNV 
disease
The full correlation matrix of the number of human cases
by county and the WNV-positive dead bird variables for
the 24 counties with human cases in 2001–2003 is shown
in Table 3. The three variables with the highest correla-
tions with human cases were A6 [Positive birds/Tested
birds], A7 [(Positive/Tested)*Population] and A8 [(Posi-
tive/Tested)*(Population/Area)].
These three variables were used in a multiple regression
analysis with the number of human cases in a county as
the predicted variable. The adjusted R-square for the
model using all three variables was 0.3949 (Table 4). As
evidenced in the correlation matrix (Table 3), variables A7
and A8 are highly correlated with each other (r = 0.77).
Variable A7 can be excluded from the analysis without sig-
nificant loss of information. The multiple regression
model with only variables A6 and A8 yielded a higher
adjusted R-square of 0.418 (Table 4). However, the corre-
lation between these two variables is also high (r = 0.454)
(Table 3). The multiple regression model with the single
variable A8 [(Positive/Tested)*(Pop/Area)] yielded the
highest adjusted R-square (Table 4). When repeating the
same analysis for predictors with low correlations
between each other (Positive, A8 and A3, Table 3), the sin-
gle variable A8 again yielded the highest adjusted R-
Table 2: Sample CMH data table for assessing relative risk of becoming a human WNV case
Week 38, 2003
Threshold = defined levela
In counties with predictor variableb ≥ threshold at 
defined time periodc before case onset
In counties with predictor variable < threshold at 
defined time period before case onset
Number of persons with disease onset 3 2
Number of persons without disease onset 3,653,369 7,013,746
aVarious threshold levels were defined to assess relative risk of becoming a human WNV case depending on predictor variable value in county of 
residence.
bPredictor variable determined with multiple regression modeling.
cTime period defined based on delay period analysis.Emerging Themes in Epidemiology 2009, 6:4 http://www.ete-online.com/content/6/1/4
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Table 3: Correlation matrix, number of human cases with positive and tested dead bird variablesa
Pearson Correlation Coefficients, N = 24 (Counties) Prob > |r| under H0: Rho = 0
P o s H u m a n s a 1 a 2a 3a 4a 5a 6a 7a 8
Pos 1.00000
Humans 0.14903 1.00000
0.4870
a1 0.91456 0.21947 1.0000
Pos/area <.0001 0.3028 0
a2 0.81757 0.22356 0.9614 1.0000
Tes/Area <.0001 0.2937 9 0
<.0001
a3 0.36780 -0.32477 0.3061 0.2949 1.00000
pos/pop 0.0770 0.1215 3 5
0.1457 0.1618
a4 - -0.27121 0.0724 0.1586 0.74098 1.00000
Pos*(pop/area) 0.05282 0.1999 0 7 <.0001
0.8064 0.7367 0.4590
a5 0.87792 0.32600 0.9314 0.9098 0.09122 - 1.00000
(Tested/area)*pop <.0001 0.1200 2 1 0.6716 0.15399
<.0001 <.0001 0.4725
a6 0.62969 0.33804 0.6689 0.5274 0.20231 - 0.53550 1.00000
Pos/Tested 0.0010 0.1062 8 4 0.3431 0.07312 0.0070
0.0004 0.0081 0.7342
a7 0.77953 0.57623 0.8162 0.7401 - - 0.88204 0.67996 1.00000
(Pos/Tes)*pop <.0001 0.0032 1 2 0.11987 0.32893 <.0001 0.0003
<.0001 <.0001 0.5769 0.1165
a8 0.28476 0.68430 0.5032 0.5051 - - 0.60591 0.45424 0.77464 1.00000
(pos/test)*(pop/are a) 0.1774 0.0002 0 9 0.38292 0.28908 0.0017 0.0258 <.0001
0.0122 0.0118 0.0648 0.1707
aEach cell provides the correlation coefficient r, and below it the probability value under the null hypothesis r = 0, α = 0.05.
New York State, 2001–2003. Humans = [human WNV cases], Pos = [birds tested positive for WNV], Tested = [birds tested for WNV], A1 = 
[Positive/Area (county land-area in square miles)], A2 = [Tested/Area], A3 = [Positive/Pop. (county human population, US Census Bureau 2000 
estimates)], A4 = [Positive*(Pop./Area)], A5 = [Tested*(Pop./area)],, A6 = [Positive/Tested], A7 = [(Positives/Tested)*Pop.] A8 = [(Positive/
Tested)*(Pop./Area)]
Table 4: Multiple regression models for prediction of the number of human WNV cases in a county
Model/Variables Adjusted R-square
Using three variables most highly correlated with number of human cases
A6, A7, A8 0.395
A6, A8 0.418
A8 0.444
Using three variables with lowest intercorrelations
A3, Pos, A8 0.394
A8, A3 0.422
A8 0.444
New York State, 2001–2003. Pos = [birds tested positive for WNV], Tested = [birds tested for WNV], A3 = [Positive/Pop. (county human 
population, US Census Bureau 2000 estimates)], A6 = [Positive/Tested], A7 = [(Positives/Tested)*Pop.], A8 = [(Positive/Tested)*(Pop./county land-
area in square miles)]Emerging Themes in Epidemiology 2009, 6:4 http://www.ete-online.com/content/6/1/4
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square. As a result of this analysis, variable A8 [(Positive/
Tested)*(Pop/Area)] was used as the predictor variable for
subsequent analyses.
Delay Period
Figure 1a shows the daily distributions of means of varia-
ble A8 [(Positive birds/Tested birds)*(Population/Area)]
and daily distribution of human cases by onset date.
Using the Kolmogorov-Smirnov test to determine the best
fit (smallest D value) for shift values from 1 to 20 between
the daily distribution of the predictor variable and the dis-
tribution of human cases, the test identified 12 days as the
optimal shift value (Figure 1b).
We also examined the smoothed plot of our two distribu-
tions (Figure 1c). We found correlations between human
cases at time t and our predictor variable at time t+p. We
determined the optimal shift p when the correlation
reached its maximum. Although the correlation reached
its maximum at 14 days, values for shifts 12, 13, 14 and
15 days were very close to each other, so the optimal shift
can be 12–15 days. Figure 1d represents the plot of values
of the correlation coefficient for the predictor variable
against shifts in days.
Estimation of WNV disease risk
The weekly value of the predictor variable [(Positive/
Tested)*(Population/Area)] was calculated for every
county in the analysis, and compared on a timeline with
human case onset. Examples for two counties in 2002 are
shown in Figure 2.
Based on the previous analysis, we defined the "delay"
period as two weeks. Several "signal" values were evalu-
ated for the variable, between 100 and 500. The county
was considered exposed if it had a "signal" value at the
time of the delay period (two weeks) before the onset of
human disease. The results of the CMH test for several sig-
nal value thresholds are presented in Table 5. In 2001 and
2002, there were no significant differences in the risk of
becoming a WNV case between people who lived in coun-
ties with the predictor dead bird variable [(Positive birds/
Tested birds)*(Population/Area)] greater than or equal to
the "signal" value and the people who lived in counties
with [(Positive birds/Tested birds)*(Population/Area)]
less than the "signal" value. For 2001, logit estimates of
relative risk were used because there were only five human
WNV cases and none of them was "unexposed". In 2003
for every threshold considered, the risk of becoming a
WNV case among people who lived in counties with the
predictor variable greater than or equal to the "signal"
value was about four times higher than the risk among
people who lived in counties with the predictor variable
less than the "signal" value. The highest relative risk was
4.87 for the threshold of 400. For all 3 years combined,
the risk of becoming WNV case for people who lived in
'exposed' counties was about two times higher than the
risk for people who lived in 'unexposed' counties, regard-
less of threshold value used.
Discussion
Previous studies have assessed the value of other WNV
variables for forecasting potential increases in human dis-
ease. In one study that used dead bird surveillance infor-
mation (WNV positive birds and tested birds) to construct
the predictor variables, the study focused on the early
transmission season, identified as a six-week period in
June-July [21]. Another study utilized dead crow sight-
ings, defining the appropriate period for forecasting as up
to two weeks before human case onset based on incuba-
tion period, but did not conduct an analysis of delay
period [24]. Many studies that tracked WNV-positive birds
reported that they were found before onset of human dis-
ease. Our study is the first statistical comparison of the
daily distributions of the dead bird predictor variable and
the number of human cases to confirm a delay period
between these two distributions. Using either raw or
smoothed data, the delay period was about two weeks,
which is consistent with the previous conclusions based
on incubation period.
The estimates of relative risk will be affected by the choice
of predictor variable. For example, most of the NY human
WNV cases in 2001–2003 were reported from counties
with a high human population density. Counties with low
population density usually had only single WNV cases
(Clinton, Orleans, and Yates counties in 2002; Warren,
Cattaraugus, Yates, and Dutchess counties in 2003). A
notable exception is Broome County in 2002, with seven
human WNV cases. Although the overall county human
population density in Broome County is relatively low
(283.64 persons per square mile), the cases were clustered
around the higher population density city of Binghamton.
Because the analyses for this study were done at the
county level, Broome County was classified as not
'exposed' for the dead bird predictor variable thresholds
we considered. This may be one factor affecting the low
relative risk estimates for 2002.
To address the issue of the large variation in population
density among counties, future studies may benefit from
combining data from several states and grouping counties
with similar population densities. Different threshold val-
ues may be applicable for each group. Another approach
would be to assign weights to each county according to its
population density, to account for the large variation
among counties. The weights can be determined, for
example, as a ratio of the population densities of the most
populated county to the given county. When the deadEmerging Themes in Epidemiology 2009, 6:4 http://www.ete-online.com/content/6/1/4
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Assessment of delay period between predictor variable [(Positive/Tested)*(Pop./Area)] per county and number of human  WNV disease cases Figure 1
Assessment of delay period between predictor variable [(Positive/Tested)*(Pop./Area)] per county and 
number of human WNV disease cases. (a) Average of predictor variable (solid curve) versus number of human WNV 
cases (column bars), by day of transmission period (CDC weeks 26–41). (b) Results of two-sample Kolmogorov-Smirnov test 
statistic D analysis, for daily distribution of average of predictor variable and number of human cases. (c) Smoothed adjacent 
point averaging with degree n = 25 points. The smoothed value at day t is the average of the data points in the interval [t-(n-1)/
2, t+ (n-1)/2], inclusive. Solid curve represents the predictor variable, dashed curve the human cases. (d) Correlation coeffi-
cients between smoothed distributions.
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bird predictor variable is multiplied by this weight, the
counties will become more comparable.
In interpreting these findings, several limitations of the
study methodology must be considered. Reporting of
dead birds was a passive system, depending solely on the
public. Variability in reporting interest between counties
could lead to misclassification on the predictor variable,
reducing the chance of detecting an association. Not all
reported dead birds were collected and tested, which
could also affect estimates of the predictor variable. Only
reported human cases were used in the analysis, and thus
human infection (either asymptomatic or mild, and thus
unreported) was likely rarely recognized and reported.
This would also reduce the statistical power of detecting
an association. The number of NY human cases was rela-
tively small in each year compared to some other states,
especially in 2001, which was one reason for conducting
Predictor dead bird variable [(Positive/Tested)*(Population/Area)] and number of human WNV disease cases by week, 2002,  Westchester and Suffolk counties, New York Figure 2
Predictor dead bird variable [(Positive/Tested)*(Population/Area)] and number of human WNV disease cases 
by week, 2002, Westchester and Suffolk counties, New York.
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our analyses at the county level. With a larger number of
cases, analyses could be done at the sub-county level
allowing more precise interpretation of risk for vector con-
trol decisions. Infection in other counties due to move-
ment of humans and birds will lead to misclassification
and reduction of statistical power. Although the relative
risks were elevated using the threshold values in the study
for all three years, they were only statistically significant
for 2003 and all three years combined. More years of data,
or combining data across states, would increase the power
of our analysis.
Estimation of WNV risk using the CMH test has limita-
tions based on the parameters chosen for this study. This
study restricted county entry into the study by having at
least 10 birds tested during the transmission season, and
the effect of using other numbers of birds for determining
inclusion was not examined. Because the predictor varia-
ble is [(Positive/Tested)*(Population/Area)], higher lev-
els of birds tested per week could be considered in order
to justify that a county has sufficient surveillance to war-
rant inclusion in the study. Different threshold values
could also be considered, and may be appropriate in areas
with different WNV disease dynamics and different sur-
veillance systems. The predictor variable consists of two
parts: proportion of positive birds and human population
density. The proportion can take values between zero and
one; therefore the maximum value of our predictor varia-
ble is the population density of the particular county.
Counties with small population densities may never be
able to reach specific threshold values to provide a 'signal'
of risk. On the other hand, their small human population
size indicates an inherent lower risk of those counties hav-
ing a human case, in comparison to counties with higher
human populations even with the same proportion of
infected mosquitoes and birds. Thus, regional rather than
county analyses may be more useful in more sparsely pop-
ulated areas, particularly if such analyses can compare
urban and rural areas. However, if using the analyses to
determine specific prevention and control activities based
on having a "signal" of risk, analyses in smaller geo-
graphic units can be more helpful in determining where to
target those interventions. Finally, these "signals" were
generated based on bird surveillance alone, and it is pos-
sible that "signals" developed that also incorporated mos-
quito surveillance data might offer even better prediction
of human case risk, but mosquito surveillance data is
often not widely available with rapid test results for real-
time analyses.
In New York State, decisions about WNV prevention and
control are primarily made at the county level. These deci-
sions have resource consequences, and use of chemicals
for mosquito control can raise concerns. Thus, decision-
making is usually based on a wide variety of inputs to help
determine level of risk and need for control, including
more focal information such as dead bird clusters or areas
with high mosquito infection rates. Previous studies have
indicated the value of dead bird indicators [7-16,21,24],
and this study provides a novel statistical approach to
demonstrate the value of using WNV-infected dead birds
as initial indicator of WNV disease risk for a county. Sig-
nals values of our weekly predictor variable above all of
the threshold values evaluated in this study were associ-
ated with increased risk of WNV disease, with significant
associations in one year and across the three years of the
study. The North American WNV strain appears to be a
phenotype highly virulent to American crows [25]. How-
ever, dead bird indicators using American crows may be of
less value in the future if there are reductions in the case
fatality rate or reduced numbers of birds for surveillance
due to WNV die-offs.
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